−1.32 HKD
−1.04 B HKD
0.00 HKD
277.45 M
About HIGHTIDE THERAPEUTICS INC.
Sector
CEO
Li Ping Liu
Headquarters
Shenzhen
Website
Founded
2011
FIGI
BBG01KK3SJW8
Hightide Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders with large and unsatisfied market needs. The company was founded by Li Ping Liu in 2011 and is headquartered in Shenzhen, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2511 is 1.14 HKD — it has increased by 6.54% in the past 24 hours. Watch HIGHTIDE THERAPEUTICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HIGHTIDE THERAPEUTICS INC. stocks are traded under the ticker 2511.
2511 stock has risen by 18.75% compared to the previous week, the month change is a 7.55% rise, over the last year HIGHTIDE THERAPEUTICS INC. has showed a −90.44% decrease.
2511 reached its all-time high on Jan 2, 2024 with the price of 13.18 HKD, and its all-time low was 0.72 HKD and was reached on Sep 10, 2024. View more price dynamics on 2511 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2511 stock is 11.54% volatile and has beta coefficient of 1.37. Track HIGHTIDE THERAPEUTICS INC. stock price on the chart and check out the list of the most volatile stocks — is HIGHTIDE THERAPEUTICS INC. there?
Today HIGHTIDE THERAPEUTICS INC. has the market capitalization of 586.84 M, it has decreased by −3.09% over the last week.
Yes, you can track HIGHTIDE THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
2511 net income for the last half-year is −228.59 M HKD, while the previous report showed −420.86 M HKD of net income which accounts for 45.69% change. Track more HIGHTIDE THERAPEUTICS INC. financial stats to get the full picture.
No, 2511 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 66.00 employees. See our rating of the largest employees — is HIGHTIDE THERAPEUTICS INC. on this list?
Like other stocks, 2511 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIGHTIDE THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIGHTIDE THERAPEUTICS INC. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIGHTIDE THERAPEUTICS INC. stock shows the neutral signal. See more of HIGHTIDE THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.